2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
about
Clinical Utility of Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI) in Gastrointestinal Cancers18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma.Relation between fluorodeoxyglucose uptake and glucose transporter-1 expression in gastric signet ring cell carcinoma.Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma.Prognostic significance of the standardized uptake value of pre-therapeutic (18)F-FDG PET in patients with malignant lymphoma.Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.18FDG, [18F]FLT, [18F]FAZA, and 11C-methionine are suitable tracers for the diagnosis and in vivo follow-up of the efficacy of chemotherapy by miniPET in both multidrug resistant and sensitive human gynecologic tumor xenografts.Development of a novel orthotopic non-small cell lung cancer model and therapeutic benefit of 2'-(2-bromohexadecanoyl)-docetaxel conjugate nanoparticles.5'-AMP-activated protein kinase increases glucose uptake independent of GLUT4 translocation in cardiac myocytes.Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches.Inhibition of mitochondrial fission prevents cell cycle progression in lung cancerGene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation.Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.[18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer.2-Deoxyglucose conjugated platinum (II) complexes for targeted therapy: design, synthesis, and antitumor activity.Tumor cell uptake of 99mTc-labeled 1-thio-β-D-glucose and 5-thio-D-glucose in comparison with 2-deoxy-2-[18F]fluoro-D-glucose in vitro: kinetics, dependencies, blockage and cell compartment of accumulation.Caged [(18)F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography.Impact of Plasma Glucose Level at the Time of Fluorodeoxyglucose Administration on the Accuracy of FDG-PET/CT in the Diagnosis of Pancreatic Lesions.Intense FDG uptake in an intra-articular localized giant-cell tumor of the tendon sheath (pigmented villonodular synovitis) mimics metastatic melanoma.Fluorine-18 Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma: Correlation with Glucose Transporters and p53 Expression.High 18F-FDG uptake in PMAH correlated with normal expression of Glut1, HK1, HK2, and HK3.Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer.Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer.Effect of glucose availability on glucose transport in bovine mammary epithelial cells.
P2860
Q28074096-F8753A7D-F332-492B-AAF1-AE7B9E5E2D5EQ30654615-58F3872E-C03B-4523-8B00-93FC1CDCF569Q33704181-F99ED19F-6100-44D2-869B-37E0E09ACE18Q33761744-0493340C-ED9C-4624-B18C-0C4F6B4BE410Q34119062-E890147A-B781-4568-9E39-E9A403AB84B8Q34204238-50C2E242-EFE2-4E00-BE75-58710E8B3DDFQ34278079-0F009D5D-2D72-40A3-9B54-D1F3840E205EQ34289406-B6EB1F57-385D-4E59-9A15-022174C3D705Q35140908-9655B450-93F7-4587-8864-6F5B3E4DE7B8Q35675442-AC470309-0B14-4FBB-8A74-B0804CE06312Q35913045-2530E8A2-34D6-4848-A126-D6F1C9433AF5Q36335121-98085F0C-C123-4479-A0F4-B703E87983B1Q36557906-BE6940D2-4B6D-429B-B6DD-963DD8904FC0Q36901233-E1793D2F-24AD-4B74-9118-571A41FC9C79Q38822944-BC405048-4A27-4DB6-AC00-9399E630F35EQ39092103-F80EA1E9-7FC4-4ABF-B2EF-90D44310E5F7Q40914549-CD227411-EAC4-441E-A069-C60C1B4A2364Q41825635-13A6AEF9-4823-438C-9E48-B5B5E72EE14AQ42737435-1806D20A-2605-41AB-82AB-8A751C34E1E8Q43189620-0E45DAAF-19DD-4EA3-B741-B49DC36452D6Q53021765-F6BA035D-94A1-4194-B5C8-2D1CE35D4D1CQ53062665-3A5248E7-ADE9-464E-813B-34CF5668F9DBQ53193315-9112E7C2-C5F2-429A-8FB1-8CC8B5EFE746Q54318103-BDC52EB8-0F9F-4ABD-81FC-9C2A7E4A3A4E
P2860
2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
2-[18F]-2-deoxy-D-glucose (FDG ...... n of GLUT-1 and hexokinase II.
@en
2-[18F]-2-deoxy-D-glucose
@nl
type
label
2-[18F]-2-deoxy-D-glucose (FDG ...... n of GLUT-1 and hexokinase II.
@en
2-[18F]-2-deoxy-D-glucose
@nl
prefLabel
2-[18F]-2-deoxy-D-glucose (FDG ...... n of GLUT-1 and hexokinase II.
@en
2-[18F]-2-deoxy-D-glucose
@nl
P2093
P1433
P1476
2-[18F]-2-deoxy-D-glucose (FDG ...... n of GLUT-1 and hexokinase II.
@en
P2093
P304
P356
10.1080/02841850802482486
P407
P50
P577
2008-12-01T00:00:00Z